Loading stock data…
RVTY
$86.68+0.06 (+0.07%)
Market ClosedLast close May 1
Revvity, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Revvity, Inc. in the Healthcare sector is trading at $86.68. The stock is currently near its 52-week low of $81.22, remaining 8.0% below its 200-day moving average. Technical signals show neutral RSI of 39 and bearish MACD signal, explaining why RVTY maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 39) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$86.68
Potential Downside
59%
Whystock Fair Value$35.58
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Buy
Mean target$113.93+31.4%
Range$95.00 – $140.00
Fundamentals
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.54B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
45.77
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.13
Div Yield
Strong income play. Yield provides a meaningful total return floor.
30.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.93%
Volume
Today's trading volume
1.12M
Recent News
3 Reasons to Avoid RVTY and 1 Stock to Buy Instead
Revvity currently trades at $94.26 per share and has shown little upside over the past six months, posting a small loss of 1.5%. The stock also fell short of the S&P 500’s 6.1% gain during that period.
A Look At Revvity (RVTY) Valuation As Mixed Recent Returns Contrast With Undervaluation Narrative
Revvity (RVTY) is drawing investor attention after recent trading, with the stock last closing at US$93.96. Short term returns are mixed, with gains over the past week and month but a weaker performance over the past 3 months. See our latest analysis for Revvity. Viewed across longer periods, Revvity’s recent 4.95% 1 day share price return and 9.33% 1 month share price return contrast with a weaker 90 day share price return of a 16.02% decline. The 1 year total shareholder return of 4.97%...
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy costs.
Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls
Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls
RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data
Revvity launches Signals BioDesign, a cloud-based cloning platform to streamline biotech R&D workflows and boost collaboration in biologics development.